Rehmann Capital Advisory Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-63
| Closed | -$4.45K | – | 1948 |
|
|
2019
Q2 | $4.45K | Sell |
63
-3
| -5% | -$212 | ﹤0.01% | 1587 |
|
|
2019
Q1 | $5.15K | Sell |
66
-77
| -54% | -$6.01K | ﹤0.01% | 1527 |
|
|
2018
Q4 | $12.1K | Sell |
143
-412
| -74% | -$34.8K | ﹤0.01% | 998 |
|
|
2018
Q3 | $95K | Sell |
555
-8
| -1% | -$1.37K | 0.01% | 599 |
|
|
2018
Q2 | $72.7K | Sell |
563
-24
| -4% | -$3.1K | 0.01% | 658 |
|
|
2018
Q1 | $60K | Buy |
+587
| New | +$60K | 0.01% | 691 |
|